Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
about
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyRevisiting the matricellular concept.The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.Thrombospondin immune regulation and the kidney.Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
P2860
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@ast
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@en
type
label
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@ast
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@en
prefLabel
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@ast
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@en
P2093
P2860
P1476
Thrombospondin-2 therapy ameli ...... tion, and TGF-beta activation.
@en
P2093
Andrea Wagner
Bernd Hohenstein
Christian Hugo
P2860
P304
P356
10.1152/AJPRENAL.00254.2009
P577
2009-09-02T00:00:00Z